Humacyte (HUMA) Revenue & Revenue Breakdown
Humacyte Revenue Highlights
00
Humacyte Revenue by Period
Humacyte Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $1.56M | 23.91% |
| 2021-12-31 | $1.26M | -15.29% |
| 2020-12-31 | $1.49M | -75.90% |
| 2019-12-31 | $6.19M | - |
Humacyte generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Humacyte Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $10.79M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | -100.00% |
| 2022-09-30 | $31.00K | -97.62% |
| 2022-06-30 | $1.30M | 458.37% |
| 2022-03-31 | $233.00K | 31.64% |
| 2021-12-31 | $177.00K | -26.56% |
| 2021-09-30 | $241.00K | -65.07% |
| 2021-06-30 | $690.00K | 345.16% |
| 2021-03-31 | $155.00K | 25.00% |
| 2020-12-31 | $124.00K | -86.43% |
| 2020-09-30 | $914.00K | 361.62% |
| 2020-06-30 | $198.00K | -22.35% |
| 2020-03-31 | $255.00K | - |
Humacyte generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Humacyte Revenue Breakdown
Humacyte Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by segment (product or service), as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 21 |
|---|---|
| Reimbursement of certain allowable costs related to grants | $200.00K |
Latest
Humacyte's latest quarterly revenue breakdown by geography, as of Sep 21: Reimbursement of certain allowable costs related to grants (100.00%).
Humacyte Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IMCR | Immunocore | $249.43M | $75.40M |
| MIRM | Mirum Pharmaceuticals | $186.37M | $77.88M |
| NRIX | Nurix Therapeutics | $76.99M | $12.59M |
| SEER | Seer | $16.66M | $4.03M |
| CYTK | Cytokinetics | $7.53M | $463.00K |
| CRNX | Crinetics Pharmaceuticals | $4.01M | - |
| HCWB | HCW Biologics | $2.84M | $426.42K |
| LYRA | Lyra Therapeutics | $1.56M | $195.00K |
| QSI | Quantum-Si | $1.08M | $787.00K |
| MNOV | MediciNova | $1.00M | - |
| VRDN | Viridian Therapeutics | $314.00K | $86.00K |
| GPCR | Structure Therapeutics | - | - |
| KURA | Kura Oncology | - | - |
| LRMR | Larimar Therapeutics | - | - |
| KALV | KalVista Pharmaceuticals | - | - |
| HUMA | Humacyte | - | - |